-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
For adult patients with type 2 diabetes who use basal insulin therapy instead of dietary insulin in primary care practice, can continuous blood glucose monitoring improve the level of glycosylated hemoglobin (HbA1c) compared with blood glucose meter monitoring? Continuous blood glucose monitoring (CGM) has been Proved to be beneficial to adult type 2 diabetes treated with intensive insulin, but its application in type 2 diabetes treated with basal insulin instead of pre-meal insulin has not been fully studied
.
Thomas Martens et al.
Diabetes Thomas Martens Thomas Martens JAMA
This randomized clinical trial was conducted in 15 centers in the United States (registered from July 30, 2018 to October 30, 2019; follow-up completed on July 7, 2020), including type 2 diabetes who received primary care clinician diabetes care Adult patients, inject long-term or mid-term basal insulin 1-2 times a day, without dietary insulin, or without non-insulin hypoglycemic drugs
.
Randomly divided into two groups : CGM group (n = 116) or traditional blood glucose meter (BGM) monitoring group (n = 59) .Randomly divided into two groups : CGM group (n = 116) or traditional blood glucose meter (BGM) monitoring group (n = 59) .
CGM
Glycated hemoglobin level after 8 months
Glycated hemoglobin level after 8 months175 random participants (mean age 57[9] years; 88 women (50%); 92 ethnic/minority individuals [53%]; average [SD] baseline glycosylated hemoglobin level, 9.
1% [0.
The average HbA1c level in the
Compared with continuous blood glucose monitoring, HbA1c levels were significantly reduced at 8 months
Martens T, Beck RW, Bailey R, et al.
Martens T, Beck RW, Bailey R, et al.
Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin: A Randomized Clinical Trial.
JAMA.
2021;325(22):2262–2272.
doi :10.
1001/jama.
2021.
7444 Martens T, Beck RW, Bailey R, et al.
Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin: A Randomized Clinical Trial.
JAMA.
2021;325(22) :2262-2272.
doi:10.
1001/jama.
2021.
7444 JAMA.
Leave a message here
